Tag: mental illness

  • Psych Meds Are Not the Enemy. Bad Medicine Is

    Psych Meds Are Not the Enemy. Bad Medicine Is

    There is a dangerous difference between criticizing bad psychiatric practice and stigmatizing psychiatric illness.

    I have criticized aspects of psychiatry many times. I believe our field should be open to critique. We should question our prescribing habits. We should challenge lazy diagnosis. We should acknowledge when medications are used too quickly, continued too long, or substituted for the deeper work of psychotherapy, lifestyle change, social support, and careful clinical formulation.

    Psychiatry should never be above criticism.

    But criticism of psychiatric practice is not the same thing as denying the legitimacy of psychiatric illness.

    And right now, that line is being blurred.

    Serious Mental Illness Is Real

    One thing you will never hear me say is that psychiatric disease is not real.

    Schizophrenia is real.
    Bipolar disorder is real.
    Severe major depression is real.
    Catatonia is real.
    Psychotic depression is real.
    Obsessive-compulsive disorder can be profoundly disabling.
    Posttraumatic stress disorder can devastate a person’s life.

    These are not character flaws. They are not weakness. They are not simply failures of lifestyle, discipline, resilience, spirituality, or mindset.

    They are legitimate medical illnesses.

    That does not mean every painful experience is a disease. It does not mean every person who is grieving, anxious, overwhelmed, lonely, or struggling needs a diagnosis or a medication. In fact, one of the most important tasks in psychiatry is knowing the difference.

    Some people need medication.

    Some people need psychotherapy.

    Some people need sleep, exercise, nutrition, structure, social connection, housing, safety, meaning, accountability, or community.

    Many people need several of these at the same time.

    The goal is not to medicalize all suffering. The goal is to recognize real illness when it is present and treat it with the seriousness it deserves.

    The Problem Is Not “Medication”

    Psychiatric medications are often discussed as if they are inherently suspicious.

    But medication is not the enemy.

    Bad medicine is.

    A medication can be life-changing when used for the right condition, in the right person, at the right time, for the right reason.

    The same medication can be harmful when used carelessly, without a clear diagnosis, without follow-up, without discussion of risks and benefits, or without a plan for reassessment.

    That is not unique to psychiatry.

    Antibiotics can be lifesaving, but inappropriate antibiotic use causes harm. Opioids can be appropriate in some clinical contexts, but reckless prescribing devastated communities. Steroids can be powerful tools, but long-term unnecessary use can create major problems.

    The issue is not whether medications are “good” or “bad.”

    The issue is whether we are practicing medicine well.

    Deprescribing Matters, But It Is Not a Mental Health Policy

    Deprescribing is important.

    Every psychiatrist I know has experience reducing, simplifying, or stopping medications when the risks outweigh the benefits or when the original indication no longer makes sense.

    This is not a fringe idea. It is part of daily psychiatric practice.

    We stop medications that are not helping.
    We reduce unnecessary polypharmacy.
    We simplify regimens when possible.
    We monitor side effects.
    We reassess diagnoses.
    We talk with patients about what still makes sense.

    Good psychiatry includes deprescribing.

    But deprescribing alone will not solve the mental health crisis.

    People cannot deprescribe their way out of a lack of psychiatric beds. They cannot deprescribe their way out of months-long waitlists. They cannot deprescribe their way out of poverty, homelessness, trauma, addiction, loneliness, or a collapsing continuum of care.

    And they cannot deprescribe their way out of schizophrenia, mania, catatonia, psychotic depression, or severe melancholic depression.

    When we frame the mental health crisis primarily as a problem of overprescribing, we oversimplify a system failure.

    We ignore the shortage of psychiatrists. We ignore the lack of access to psychotherapy. We ignore inadequate visit times, fragmented care, insurance barriers, emergency departments boarding psychiatric patients for days, and the near disappearance of a true continuum of care.

    Those are not solved by telling people to take fewer medications.

    The Risk of Stigma Dressed Up as Reform

    My concern is not that we are talking about prescribing quality. We should be talking about that.

    My concern is that the rhetoric around psychiatric medications often sends a dangerous message to people who already feel ashamed.

    Many patients with serious mental illness already struggle with the idea of needing medication.

    They worry it means they are weak.
    They worry it means they are broken.
    They worry it means they are dependent.
    They worry it means they are not trying hard enough.
    They worry others will see them differently.

    When public conversations frame psychiatric medications as the central villain, those patients hear something very different from “we need better prescribing.”

    They hear:

    You are dependent.
    You are addicted.
    You are taking the easy way out.
    You should be able to fix this naturally.
    You are the problem.

    That is not empowerment.

    That is stigma.

    And for some patients, that stigma can be dangerous. It can lead people to stop medications abruptly, avoid treatment, disengage from care, relapse, or delay help until a crisis occurs.

    Of course patients should be informed. Of course they should understand risks and benefits. Of course they should have a voice in treatment decisions.

    But informed consent should not become fear-based messaging. And reform should not become another way of shaming people with serious psychiatric illness.

    Better Medicine Means Holding Two Truths

    The future of psychiatry depends on our ability to hold two truths at the same time.

    First, psychiatric illness is real and can be devastating.

    Second, psychiatry must be careful not to overdiagnose, overprescribe, or turn normal human suffering into lifelong pathology.

    Both truths matter.

    If we only emphasize the first, we risk medicalizing everything.

    If we only emphasize the second, we risk abandoning people with serious illness.

    Real psychiatric care lives in the tension between those truths.

    It requires humility. It requires careful diagnosis. It requires honest conversations about uncertainty. It requires medication when appropriate, psychotherapy when appropriate, lifestyle intervention when appropriate, social support when appropriate, neuromodulation when appropriate, and deprescribing when appropriate.

    It also requires us to say clearly that some people need medication, and that needing medication is not a moral failure.

    The Goal Is Better Medicine

    The goal is not to prescribe more.

    The goal is not to prescribe less.

    The goal is to prescribe better.

    Better diagnosis.
    Better informed consent.
    Better follow-up.
    Better access to psychotherapy.
    Better use of lifestyle interventions.
    Better systems of care.
    Better deprescribing when medications are no longer needed.
    Better protection for people whose medications are the reason they are alive, stable, working, parenting, studying, and functioning.

    We do not fix psychiatry by pretending psychiatric medications are always the answer.

    But we also do not fix psychiatry by pretending they are the enemy.

    Psych meds are not the enemy.

    Bad medicine is.

  • The future of psychiatry depends on whether DSM-6 has the courage to say something unpopular

    The future of psychiatry depends on whether DSM-6 has the courage to say something unpopular

    My latest article in Psychiatric Times  https://www.psychiatrictimes.com/view/psychiatry-does-not-need-a-softer-dsm-it-needs-a-smarter-one

    Not all distress is disease

    That does not minimize suffering

    It protects the seriousness of psychiatric illness

    Some people have schizophrenia, bipolar disorder, OCD, severe depression, catatonia, and other conditions that can devastate lives without accurate diagnosis and treatment

    Others are suffering from trauma, stress, grief, substance use, medical illness, social collapse, personality structure, or environmental chaos

    They still deserve care

    But care does not always require a lifelong diagnostic label

    That is the tension DSM-6 must confront

    If the next DSM becomes broader, softer, and more flexible without becoming more scientifically valid, psychiatry will not gain credibility. It will lose it.

    My latest article in Psychiatric Times argues that psychiatry does not need a softer DSM.

    It needs a smarter one.

  • Challenges of Antidepressant Management in Primary Care

    Challenges of Antidepressant Management in Primary Care

    Discussions about the potential overprescribing of antidepressants must begin with an understanding of who is doing most of the prescribing. In the U.S., primary care physicians (PCPs) write the majority of antidepressant prescriptions, with estimates suggesting that 60–80% originate from primary care rather than psychiatry (Mojtabai & Olfson, 2011; Mark et al., 2014). This prescribing pattern reflects broader trends in mental health treatment, where primary care has become the frontline for managing depression and other mood disorders.

    Several factors contribute to this dynamic:

    • Limited access to psychiatrists: Many patients, especially in rural or underserved areas, face long wait times or geographic barriers to seeing a psychiatrist.
    • Overlap with medical conditions: PCPs frequently manage conditions like chronic pain, insomnia, and fatigue, for which antidepressants may be considered as part of the treatment plan.
    • Continuity of care: Patients often have longstanding relationships with their primary care providers, making them more comfortable discussing mood symptoms in this setting.
    • Psychiatric referral limitations: Many psychiatrists focus on complex or treatment-resistant cases, meaning initial treatment often falls under primary care.

    Challenges and Considerations

    While primary care plays a crucial role in mental health treatment, concerns exist regarding the effectiveness of antidepressant management in this setting:

    • Suboptimal dosing and medication selection: Studies suggest that antidepressants prescribed in primary care settings may be dosed too low or not adequately adjusted, potentially leading to partial response or treatment failure (Carrasco & Sandner, 2005). Additionally, there is a higher likelihood of using older antidepressants, which may have a less favorable side effect profile.
    • Lack of therapy integration: Guidelines recommend a combination of medication and psychotherapy for moderate-to-severe depression (APA, 2010), yet PCPs may have limited time, training, or referral resources to ensure therapy is included.
    • Potential misdiagnosis: Depressive symptoms can overlap with other psychiatric and medical conditions, leading to misdiagnosis or inappropriate treatment. For example, bipolar disorder is often misdiagnosed as major depressive disorder in primary care, which can result in inadequate treatment and risk of mood destabilization (Hirschfeld et al., 2003).

    Addressing These Challenges

    Several strategies can improve antidepressant management within primary care settings:

    • Collaborative care models: Studies show that integrating mental health professionals within primary care teams leads to improved outcomes, including higher remission rates and better adherence (Archer et al., 2012).
    • Standardized screening and follow-up: Implementing tools like the PHQ-9 for monitoring depression severity can help guide treatment decisions and ensure timely adjustments.
    • Education and decision support: Providing PCPs with continuing education on psychiatric prescribing and decision-support tools can enhance treatment precision.
    • Improved access to therapy: Expanding tele-therapy options and embedding behavioral health providers in primary care clinics can help bridge the gap between medication and psychotherapy.

    Conclusion

    Given the high volume of antidepressant prescriptions originating from primary care, ensuring optimal management is critical to improving patient outcomes. Strengthening collaboration between PCPs and mental health specialists, enhancing diagnostic accuracy, and integrating therapy referrals can help address current limitations.

    Call to Action: If you are a healthcare professional involved in prescribing antidepressants, what strategies have you found effective in improving patient outcomes? Share your insights and experiences below.

  • Mindfulness and Meditation for ADHD: A Natural Boost for Focus and Calm

    Mindfulness and Meditation for ADHD: A Natural Boost for Focus and Calm

    ADHD often brings challenges like racing thoughts, impulsivity, and difficulty staying focused. Mindfulness and meditation are powerful tools that can help individuals with ADHD calm their minds, enhance focus, and reduce stress.

    What is Mindfulness?

    Mindfulness is the practice of paying attention to the present moment without judgment. It involves observing your thoughts, feelings, and surroundings with curiosity and acceptance.

    For individuals with ADHD, mindfulness can help manage the constant stream of thoughts and improve attention regulation.

    Benefits of Mindfulness and Meditation for ADHD

    1. Improved Focus: Regular mindfulness practice helps train the brain to redirect attention back to the task at hand.
    2. Reduced Impulsivity: Mindfulness strengthens self-awareness, helping individuals pause before reacting.
    3. Lower Stress Levels: Deep breathing and meditation activate the relaxation response, countering ADHD-related anxiety.
    4. Better Emotional Regulation: Mindfulness helps identify and manage strong emotions before they escalate.

    The Evidence: Mindfulness for ADHD

    Research supports mindfulness and meditation as effective interventions for ADHD:

    • 2018 meta-analysis found that mindfulness-based interventions significantly improved attention, impulsivity, and emotional regulation in children and adults with ADHD.
    • 2016 RCT reported that mindfulness training reduced ADHD symptoms and improved executive functioning in adults.

    How to Start a Mindfulness Practice for ADHD

    1. Breathing Exercises

    • What to Do:
      • Sit comfortably.
      • Focus on your breath as it flows in and out.
      • If your mind wanders, gently bring your focus back to your breath. Allow thoughts to come and go, don’t hold onto them
    • Duration: Start with 2–5 minutes and gradually increase to 10–15 minutes.
    • Why it Works: Deep breathing calms the nervous system and anchors attention.

    2. Body Scan Meditation

    • What to Do:
      • Lie down or sit comfortably.
      • Close your eyes and focus on each part of your body, starting from your toes and moving upward.
      • Notice sensations, tension, or relaxation.
    • Duration: 5–10 minutes.
    • Why it Works: Increases body awareness and reduces physical restlessness.

    3. Mindful Walking

    • What to Do:
      • Walk slowly and focus on the sensations of your feet touching the ground.
      • Pay attention to the rhythm of your steps and the sounds around you.
    • Duration: 5–10 minutes during breaks or daily walks.
    • Why it Works: Combines movement with mindfulness, making it ADHD-friendly.

    4. Guided Meditations

    • What to Do: Use mindfulness apps like CalmHeadspace, or Insight Timer for ADHD-specific guided sessions.
    • Duration: Sessions range from 5 to 30 minutes.
    • Why it Works: Guided meditations provide structure, making it easier to stay engaged.

    5. One-Minute Check-Ins

    • What to Do:
      • Pause for one minute during the day to notice your breath, thoughts, or surroundings.
      • Ask yourself, “What’s happening right now?”
    • Why it Works: Quick mindfulness breaks ground your attention and reduce overwhelm.

    Tips for Success

    • Start Small: Begin with short sessions and gradually increase as your comfort grows.
    • Be Patient: It’s normal for the ADHD mind to wander. The goal is to notice and gently refocus.
    • Practice Consistently: Aim for 3–5 sessions per week to build the habit.
    • Integrate into Daily Life: Use mindfulness during daily tasks, like eating or brushing your teeth, to stay present.
  • The parallels between the psychiatric asylums and modern inpatient psychiatric treatment 

    The parallels between the psychiatric asylums and modern inpatient psychiatric treatment 

    The history of psychiatric asylums is a dark chapter in mental health care, yet the more I reflect on it, the more I see troubling parallels between the asylum era and our modern system of inpatient psychiatric treatment.

    Asylums, in their earliest forms, were created with good intentions: to provide care for those with severe mental illnesses and intellectual disabilities who could not be safely or adequately treated in their communities. However, as these institutions became overcrowded, underfunded, and poorly staffed, they devolved into places of neglect, abuse, and suffering. The eventual closures of these institutions were a necessary response to the horrific conditions exposed, but the underlying issues didn’t disappear. They merely shifted.

    Today, many of the same challenges persist in our modern inpatient psychiatric system. Patients with severe mental illnesses or disabilities still require long-term care, but instead of asylums, they are placed in short-term facilities. These hospitals are often understaffed and overburdened, operating under financial pressures to prioritize quick turnover rather than long-term recovery. It’s not uncommon for patients to be admitted, stabilized just enough for discharge, and then readmitted within weeks—sometimes even days—because the core issues remain unaddressed.

    In both the asylums of the past and the short-term psychiatric hospitals of today, patients often receive the same types of medications and therapies. The difference is that today’s treatment settings operate under stricter legal frameworks aimed at preserving patient rights, but the lack of continuity and depth in treatment results in a revolving door of care. Rather than focusing on sustained recovery, the focus is often on crisis management and meeting insurance-imposed timelines.

    This cycle is problematic for patients and clinicians alike. For patients, it results in frustration, instability, and a lack of meaningful progress. For healthcare workers, it leads to burnout, similar to what was seen in the asylum era. The system, despite its modern façade, hasn’t evolved enough to address the long-term needs of individuals with severe mental illnesses. Until we invest in creating a system that prioritizes long-term, comprehensive care, we risk repeating the mistakes of the past—only this time without the walls of the asylum to contain the issue.

  • Semaglutide: The Diabetes Drug with a Life-Saving Twist Against Opioid Overdose

    Semaglutide: The Diabetes Drug with a Life-Saving Twist Against Opioid Overdose

    A recent study published in JAMA Network Open investigated the relationship between semaglutide, a medication commonly used for type 2 diabetes (T2D), and the risk of opioid overdose in patients with both T2D and opioid use disorder (OUD). The researchers analyzed the health records of over 33,000 individuals, finding that those taking semaglutide had a significantly lower risk of opioid overdose compared to those using other diabetes medications. Semaglutide reduced overdose risk by as much as 58% when compared to insulin, and by 54% compared to metformin.

    The findings suggest that semaglutide may have protective effects in people with OUD and T2D, although more research is needed to confirm the mechanisms behind these effects and to validate the results through clinical trials. Researchers emphasized that these promising outcomes highlight the potential therapeutic value of semaglutide beyond diabetes management, though the study faced limitations due to its observational design and the possibility of uncontrolled variables.

    Further research is required to understand how semaglutide could be integrated into treatment strategies for opioid use disorder​

    Link to the article: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2824054?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=092524&adv=null

  • Locked Out: Why Most Inmates Are Denied Life-Saving Opioid Treatment

    Locked Out: Why Most Inmates Are Denied Life-Saving Opioid Treatment

    The JAMA Network Open article titled “Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails” investigates the availability of medications for opioid use disorder (MOUD) in U.S. jails, such as methadone, buprenorphine, and naltrexone. It highlights that MOUD, which is a critical component in treating opioid use disorder (OUD), is underutilized in correctional facilities, despite its effectiveness in reducing overdose rates, withdrawal symptoms, and recidivism.

    Key factors influencing MOUD availability in jails include jail size, regional location, the political landscape, and resources available in the facility. Jails in larger urban areas or those in states with Medicaid expansion are more likely to provide MOUD. Barriers such as stigma, lack of funding, and inadequate healthcare infrastructure also limit access to these medications.

    The study emphasizes the importance of expanding access to MOUD in jails to address the opioid epidemic and improve public health outcomes for incarcerated populations as only 44% of jails offer MOUD in the current system. 

  • The Journey to Becoming the Best Version of Yourself

    The Journey to Becoming the Best Version of Yourself

    I’ve never shared this story before, but lately, I’ve been reflecting on what it truly means to grow, to fight your inner battles, and become the best version of yourself. From the beginning, I knew that before I could serve others, I had to conquer my own demons — embark on my very own hero’s journey.

    For those unfamiliar with the old way of landing a residency before the pandemic, let me tell you—it was intense. As a fourth-year med student, you would travel across the country, conducting interviews in person. The nerves of sitting in a room with a program director, explaining why you were the right fit, were real. But there’s something irreplaceable about sitting face-to-face with someone, feeling their energy, picking up on their vibe. It told you whether or not you could actually work with that person. That is something lost in today’s tele-interviews, and honestly, it’s a lesson that extends beyond medical school—it’s about life and human connection.

    I vividly remember interviewing at a program where my final interview was with the director. We sat in silence for a minute as she looked over my CV. She didn’t introduce herself, didn’t ask how I was, just silence. Then, she saw the hobbies section where I had written that I enjoyed self-improvement seminars and books. Her reaction? She immediately began grilling me.

    “You like reading self-help books?” she asked, and I could feel the judgment. I told her I prefer to call it ‘education,’ but in her eyes, I had already failed. She looked at me as if someone on a journey to improve themselves didn’t belong there. She ended the interview right then, essentially telling me I wasn’t cut out for her program.

    At the time, I was hurt—angry, even. I felt like I had been dismissed for being human, for not being perfect. But that interaction has aged well. Today, I don’t look back with the same anger; instead, I see it as a powerful lesson.

    Here’s the thing: the expectation that we should be “perfect” is a lie. We are all works in progress. None of us have it all figured out, despite what social media shows. And that’s okay—it’s something to embrace, not run from.So to anyone out there, especially future psychiatrists, remember this: your own journey matters. The process of growth never ends, and it’s the imperfections that make us human—and that’s where real strength lies.

  • Strengthening Mental Health Parity: Ensuring Equal Access to Affordable Care

    Strengthening Mental Health Parity: Ensuring Equal Access to Affordable Care

    Here are the key points from the Biden Administration’s finalized regulation:

    1. Objective: To ensure 175 million Americans with private health insurance have access to affordable mental health services.
    2. Focus: The regulation emphasizes mental health care parity, aiming for equal access and affordability between mental and physical health services.
    3. Requirements for Insurers: Health insurance providers must cover mental health services comparably to physical health services, without added hurdles.
    4. Implementation: Insurers are required to assess the adequacy of their mental health networks and take corrective action if they fall short.
    5. Broader Impact: The rule seeks to reduce out-of-pocket costs and improve access to essential mental health treatments, addressing the growing mental health crisis.
  • Ketamine: A Temporary Fix, Not a Cure for Depression

    Ketamine: A Temporary Fix, Not a Cure for Depression

    It’s crucial to understand that ketamine is not a cure for depression. Many individuals experience a relapse, often within 2 to 4 weeks after finishing the initial treatment. If you’re expecting ketamine to fully resolve your depression, this could lead to disappointment and potentially harmful consequences.